Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ITACITINIB for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where ITACITINIB was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for ITACITINIB

Side Effect Reports % Deaths Hosp.
Diarrhoea 23 10.7% 2 23
Febrile neutropenia 23 10.7% 4 23
Pneumonia 23 10.7% 8 21
Pyrexia 21 9.7% 4 21
Cytomegalovirus infection 19 8.8% 2 19
Thrombocytopenia 17 7.9% 4 14
Acute kidney injury 15 6.9% 7 14
Fatigue 15 6.9% 0 15
Platelet count decreased 15 6.9% 0 15
Abdominal pain 13 6.0% 0 13
Asthenia 13 6.0% 0 13
Sepsis 13 6.0% 10 13
Pancytopenia 12 5.6% 2 11
Septic shock 12 5.6% 9 9
Cytomegalovirus viraemia 9 4.2% 0 9

Other Indications for ITACITINIB

Acute graft versus host disease (92) Chronic graft versus host disease (24) Bronchiolitis obliterans syndrome (20) Graft versus host disease (20) Prophylaxis against graft versus host disease (16) Acute graft versus host disease in skin (6) Product used for unknown indication (6)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

ITACITINIB Full Profile All Diffuse large b-cell lymphoma Drugs ITACITINIB Demographics ITACITINIB Timeline